Press "Enter" to skip to content

New patent for Janssen Biotech drug ERLEADA

0
Copyright © DrugPatentWatch. Originally published at New patent for Janssen Biotech drug ERLEADA

Annual Drug Patent Expirations for ERLEADA
Annual Drug Patent Expirations for ERLEADA

Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.

Drug patent litigation for ERLEADA.

This drug has one hundred and fifty-five patent family members in forty countries.

The generic ingredient in ERLEADA is apalutamide. One supplier is listed for this compound. Additional details are available on the apalutamide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Janssen Biotech drug ERLEADA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions